Scientific Program Objectives
- Discuss the latest advances to improve cord blood transplantation and the successful development of novel therapies for the treatment of non-hematologic diseases.
- Identify differing approaches to commercialization and strategies to create new business models.
- Evaluate the current industry and technological advances in perinatal cell and tissue processing, storage and potential applications in the clinic.
- Understand the changing legislation of 21st Century Cures and its potential effect on the banking, transplant and regenerative medicine industries.
View the Scientific Program.